Baxter stock (NYSE: BAX) currently trades at $41 per share, more than 50% lower than the level seen in March 2021, and it can see higher levels over time. BAX stock was trading at around $64 in early ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Despite beating revenue estimates, Baxter International’s ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced a comprehensive strategic roadmap to meaningfully enhance its operational ...

Baxter stock (NYSE: BAX), a healthcare company, currently trades at $38 per share, more than 50% lower than the level seen in February 2022. BAX stock has fared worse than its peer – Becton, Dickinson ...

Narrow-moat Baxter mildly beat adjusted EPS expectations in the second quarter and raised the bottom end of its adjusted EPS guidance range for 2021. However, this mild increase in near-term profit ...

The Federal Reserve's rate cut historically boosts healthcare stocks, and Baxter International's recent downturn presents a buying opportunity due to overblown market reactions. Baxter's acquisition ...

Narrow-moat Baxter beat adjusted EPS expectations in the first quarter and raised its 2021 outlook. After accounting primarily for cash flows generated since our last valuation update and also ...